Foxo3a Expression Is a Prognostic Marker in Breast Cancer

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Jiang, Ying ^a,b   Zou, Lin ^b   Lu, Wei Qi ^a   Zhang, Yong ^a   Shen, Ai Guo ^b  

^a FUDAN UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR FKHRL1; TUMOR MARKER;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDEPENDENT VARIABLE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POPULATION RESEARCH; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; AGED; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84881526678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070746     Document Type: Article

References (44)

1. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, et al. (1996) Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14: 2197-2205.
2. Giannakou ME, Goss M, Junger MA, Hafen E, Leevers SJ, et al. (2004) Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 305: 361.
3. Hwangbo DS, Gershman B, Tu MP, Palmer M, Tatar M, (2004) Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 429: 562-566.
4. Lin K, Hsin H, Libina N, Kenyon C, (2001) Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 28: 139-145.
5. Medema RH, Kops GJ, Bos JL, Burgering BM, (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787.
6. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, et al. (2000) Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 20: 9138-9148.
7. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ, (2000) Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10: 1201-1204.
8. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
9. Ticchioni M, Essafi M, Jeandel PY, Davi F, Cassuto JP, et al. (2007) Cassuto JPHomeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 26: 7081-7091.
10. Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, et al. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128: 309-323.
11. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, et al. (2004) IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237.
12. Belguise K, Guo S, Sonenshein GE, (2007) Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res 67: 5763-5770.
13. Lin K, Dorman JB, Rodan A, Kenyon C, (1997) daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278: 1319-1322.
14. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, et al. (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389: 994-999.
15. Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, et al. (2000) Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and-independent effects of insulin on promoter activity. J Biol Chem 275: 36324-36333.
16. Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R, et al. (2000) Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J Biol Chem 275: 30169-30175.
17. Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128: 325-339.
18. Nemoto S, Finkel T, (2002) Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 2450-2452.
19. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321.
20. Van Der Heide LP, Hoekman MF, Smidt MP, (2004) The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380: 297-309.
21. Essafi A, Fernandez de Mattos S, Hassen YA, Soeiro I, Mufti GJ, et al. (2005) Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24: 2317-2329.
22. Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, et al. (2002) FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol 156: 531-542.
23. Sunters A, Fernandez de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, et al. (2003) FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 278: 49795-49805.
24. Accili D, Arden KC, (2004) FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421-426.
25. Burgering BM, Kops GJ, (2002) Cell cycle and death control: long live Forkheads. Trends Biochem Sci 27: 352-360.
26. Ishikawa T, Shimizu D, Kito A, Ota I, Sasaki T, et al. (2012) Breast cancer manifested by hematologic disorders. J Thorac Dis 4: 650-654.
27. Leake R, (1999) Contents of HRT and mechanisms of action. J Epidemiol Biostat 4: 129-133.
28. Christinat A, Di Lascio S, Pagani O, (2013) Hormonal therapies in young breast cancer patients: when, what and for how long? J Thorac Dis 5: S36-S46.
29. Ali S, Coombes RC, (2002) Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2: 101-112.
30. Osborne CK, (1998) Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51: 227-238.
31. Fuqua SA, Chamnes GC, McGuire WL, (1993) Estrogen receptor mutations in breast cancer. J Cell Biochem 51: 135-139.
32. Delpuech O, Griffiths B, East P, Essafi A, Lam EW, et al. (2007) Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression. Mol Cell Biol 27: 4917-4930.
33. Madureira PA, Varshochi R, Constantinidou D, Francis RE, Coombes RC, et al. (2006) The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem 281: 25167-25176.
34. Zhao HH, Herrera RE, Coronado-Heinsohn E, Yang MC, Ludes-Meyers J H, et al. (2001) Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions. J Biol Chem 276: 27907-27912.
35. Zou Y, Tsai WB, Cheng CJ, Hsu C, Chung YM, et al. (2008) Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Res 10: R21.
36. Simpson JF, Gray R, Dressler LG, Cobau CD, Falkson CI, et al. (2000) Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J ClinOncol 18: 2059-69.
37. Allred DC, Harvey JM, Berardo M, Clark GM, (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11: 155-68.
38. Chappuis PO, Donato E, Goffin JR, Wong N, Begin LR, et al. (2005) Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment. Ann Oncol 16: 735-742.
39. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ, (2001) Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 19: 3817-3827.
40. Clark GM, McGuire WL, (1983) Prognostic factors in primary breast cancer. Breast Cancer Res Treat 3 Suppl: S69-72.
41. Alghanem AA, Hussain S, (1986) The effect of tumor size and axillary lymph node metastasis on estrogen and progesterone receptors in primary breast cancer. J Surg Oncol 31: 218-221.
42. Esteva FJ, Sahin AA, Cristofanilli M, Arun B, Hortobagyi GN, (2002) Molecular prognostic factors for breast cancer metastasis and survival. Semin Radiat Oncol 12: 319-328.
43. Habashy HO, Rakha EA, Aleskandarany M, Ahmed MA, Green AR, et al. (2011) Breast Cancer Res. Treat 129: 11-21.
44. Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu LH, et al. (2010) Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer. PLoS One 5: e12293.